NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,241,026 | -23.4% | 139,454 | -17.0% | 0.01% | -20.0% |
| Q1 2023 | $2,924,184 | +60.9% | 167,960 | -20.4% | 0.01% | +42.9% |
| Q3 2022 | $1,817,000 | -13.7% | 210,992 | -18.4% | 0.01% | -12.5% |
| Q2 2022 | $2,106,000 | +28.4% | 258,443 | +91.4% | 0.01% | +60.0% |
| Q1 2022 | $1,640,000 | -36.2% | 134,999 | +79.2% | 0.01% | -28.6% |
| Q4 2021 | $2,570,000 | -23.8% | 75,331 | +7.8% | 0.01% | -30.0% |
| Q3 2021 | $3,371,000 | +6.9% | 69,886 | +0.1% | 0.01% | 0.0% |
| Q2 2021 | $3,152,000 | -6.9% | 69,791 | -0.6% | 0.01% | -16.7% |
| Q1 2021 | $3,385,000 | -15.1% | 70,193 | -5.3% | 0.01% | -14.3% |
| Q4 2020 | $3,989,000 | +37.4% | 74,085 | -5.9% | 0.01% | +16.7% |
| Q3 2020 | $2,904,000 | +13.6% | 78,724 | -4.6% | 0.01% | +9.1% |
| Q2 2020 | $2,556,000 | -1.2% | 82,519 | -11.9% | 0.01% | -15.4% |
| Q1 2020 | $2,587,000 | -5.6% | 93,708 | 0.0% | 0.01% | +30.0% |
| Q4 2019 | $2,741,000 | +37.9% | 93,708 | -9.9% | 0.01% | +25.0% |
| Q3 2019 | $1,988,000 | – | 104,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,614,263 | $19,613,000 | 10.60% |
| Samjo Capital LLC | 185,000 | $2,248,000 | 1.92% |
| PERKINS CAPITAL MANAGEMENT INC | 152,550 | $1,853,000 | 1.52% |
| Cowen Prime Advisors LLC | 183,500 | $2,230,000 | 0.94% |
| First Light Asset Management, LLC | 805,958 | $9,792,000 | 0.86% |
| Soleus Capital Management, L.P. | 460,000 | $5,589,000 | 0.72% |
| Greenhouse Funds LLLP | 574,956 | $6,986,000 | 0.70% |
| Bullseye Asset Management LLC | 108,054 | $1,313,000 | 0.60% |
| Ranger Investment Management | 776,428 | $9,434,000 | 0.60% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 960,832 | $11,674,000 | 0.52% |